A network pharmacology perspective for deciphering potential mechanisms of action of Solanum nigrum L. in bladder cancer

被引:28
作者
Dong, Yang [1 ,2 ]
Hao, Lin [1 ,2 ]
Fang, Kun [3 ]
Han, Xiao-xiao [4 ]
Yu, Hui [5 ]
Zhang, Jian-jun [6 ]
Cai, Long-jun [6 ]
Fan, Tao [1 ]
Zhang, Wen-da [1 ]
Pang, Kun [1 ]
Ma, Wei-ming [1 ]
Wang, Xi-tao [1 ]
Han, Cong-hui [1 ,2 ,7 ]
机构
[1] Nanjing Univ Chinese Med, Dept Urol, XuZhou Cent Hosp, Jiefang South Rd 199, Xuzhou 199, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Clin Med, Xuzhou, Jiangsu, Peoples R China
[3] Nanjing Univ Tradit Chinese Med, Xuzhou Clin Med Coll Integrated Tradit Chinese &, Xuzhou, Jiangsu, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai First Matern & Infant Hosp, Ctr Reprod Med, Shanghai, Peoples R China
[5] Yantai Hosp Tradit Chinese Med, Yantai, Peoples R China
[6] Xuzhou Med Univ, Suqian Peoples Hosp, Dept Urol, Nanjing Drum Tower Hosp Grp,Affiliated Suqian Hos, Suqian, Peoples R China
[7] Jiangsu Normal Univ, Dept Biotechnol, Coll Life Sci, Xuzhou, Jiangsu, Peoples R China
关键词
Bladder cancer; Enrichment analysis; Network pharmacology; Solanum nigrum L; Target prediction; MESSENGER-RNA-EXPRESSION; INHIBITS CELL-GROWTH; R/BIOCONDUCTOR PACKAGE; SYSTEMS PHARMACOLOGY; DRUG DISCOVERY; DIETARY-INTAKE; WATER EXTRACT; IN-VITRO; C-MYC; ESR1;
D O I
10.1186/s12906-021-03215-3
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Solanum nigrum L. decoction has been used as a folklore medicine in China to prevent the postoperative recurrence of bladder cancer (BC). However, there are no previous pharmacological studies on the protective mechanisms of this activity of the plant. Thus, this study aimed to perform a systematic analysis and to predict the potential action mechanisms underlying S. nigrum activity in BC based on network pharmacology. Methods: Based on network pharmacology, the active ingredients of S. nigrum and the corresponding targets were identified using the Traditional Chinese Medicines for Systems Pharmacology Database and Analysis Platform database, and BC-related genes were screened using GeneCards and the Online Mendelian Inheritance in Man database. In addition, ingredient-target (I-T) and protein-protein interaction (PPI) networks were constructed using STRING and Cytoscape, Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted, and then the pathways directly related to BC were integrated manually to reveal the pharmacological mechanism underlying S. nigrum-medicated therapeutic effects in BC. Results: Seven active herbal ingredients from 39 components of S. nigrum were identified, which shared 77 common target genes related to BC. I-T network analysis revealed that quercetin was associated with all targets and that NCOA2 was targeted by four ingredients. Besides, interleukin 6 had the highest degree value in the PPI network, indicating a hub role. A subsequent gene enrichment analysis yielded 86 significant GO terms and 89 significant pathways, implying that S. nigrum had therapeutic benefits in BC through multi-pathway effects, including the HIF-1, TNF, P53, MAPK, PI3K/Akt, apoptosis and bladder cancer pathway. Conclusions: S. nigrum may mediate pharmacological effects in BC through multi-target and various signaling pathways. Further validation is required experimentally. Network pharmacology approach provides a predicative novel strategy to reveal the holistic mechanism of action of herbs.
引用
收藏
页数:14
相关论文
共 81 条
[1]   Neoadjuvant chemotherapy in invasive bladder cancer:: Update of a systematic review and meta-analysis of individual patient data [J].
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Grossman, HB ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martinez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Torti, FM ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :202-206
[2]  
An Lei, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1225
[3]   UniProt: a worldwide hub of protein knowledge [J].
Bateman, Alex ;
Martin, Maria-Jesus ;
Orchard, Sandra ;
Magrane, Michele ;
Alpi, Emanuele ;
Bely, Benoit ;
Bingley, Mark ;
Britto, Ramona ;
Bursteinas, Borisas ;
Busiello, Gianluca ;
Bye-A-Jee, Hema ;
Da Silva, Alan ;
De Giorgi, Maurizio ;
Dogan, Tunca ;
Castro, Leyla Garcia ;
Garmiri, Penelope ;
Georghiou, George ;
Gonzales, Daniel ;
Gonzales, Leonardo ;
Hatton-Ellis, Emma ;
Ignatchenko, Alexandr ;
Ishtiaq, Rizwan ;
Jokinen, Petteri ;
Joshi, Vishal ;
Jyothi, Dushyanth ;
Lopez, Rodrigo ;
Luo, Jie ;
Lussi, Yvonne ;
MacDougall, Alistair ;
Madeira, Fabio ;
Mahmoudy, Mahdi ;
Menchi, Manuela ;
Nightingale, Andrew ;
Onwubiko, Joseph ;
Palka, Barbara ;
Pichler, Klemens ;
Pundir, Sangya ;
Qi, Guoying ;
Raj, Shriya ;
Renaux, Alexandre ;
Lopez, Milagros Rodriguez ;
Saidi, Rabie ;
Sawford, Tony ;
Shypitsyna, Aleksandra ;
Speretta, Elena ;
Turner, Edward ;
Tyagi, Nidhi ;
Vasudev, Preethi ;
Volynkin, Vladimir ;
Wardell, Tony .
NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) :D506-D515
[4]   Network analyses in systems pharmacology [J].
Berger, Seth I. ;
Iyengar, Ravi .
BIOINFORMATICS, 2009, 25 (19) :2466-2472
[5]   Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data [J].
Bono, AV ;
Goebell, PJ ;
Groshen, S ;
Lehmann, J ;
Studer, U ;
Torti, FM ;
Abol-Enein, H ;
Bassi, P ;
Boyer, M ;
Coppin, CML ;
Cortesi, E ;
Hall, RR ;
Horwich, A ;
Malmström, PU ;
Martínez-Piñeiro, JA ;
Sengelov, L ;
Sherif, A ;
Wallace, DMA ;
Clarke, NW ;
Roberts, JT ;
Sylvester, R ;
Parmar, MKB ;
Stewart, LA ;
Tierney, JF ;
Vale, CL .
EUROPEAN UROLOGY, 2005, 48 (02) :189-201
[6]  
Breyer J, 2017, ONCOTARGET, V8, P67684, DOI 10.18632/oncotarget.18804
[7]   ESR1, ERBB2, and Ki67 mRNA expression predicts stage and grade of non-muscle-invasive bladder carcinoma (NMIBC) [J].
Breyer, Johannes ;
Wirtz, Ralph M. ;
Laible, Mark ;
Schlombs, Kornelia ;
Erben, Philipp ;
Kriegmair, Maximilian Christian ;
Stoehr, Robert ;
Eidt, Sebastian ;
Denzinger, Stefan ;
Burger, Maximilian ;
Hartmann, Arndt ;
Otto, Wolfgang .
VIRCHOWS ARCHIV, 2016, 469 (05) :547-552
[8]   β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling [J].
Cao, Zhang-qi ;
Wang, Xue-xi ;
Lu, Li ;
Xu, Jing-wen ;
Zhang, Guang-ru ;
Mai, Zhan-jun ;
Shi, An-chen ;
Wang, Yan ;
Song, Yu-jun .
FRONTIERS IN PHARMACOLOGY, 2019, 9
[9]   Expansion of the Gene Ontology knowledgebase and resources [J].
Carbon, S. ;
Dietze, H. ;
Lewis, S. E. ;
Mungall, C. J. ;
Munoz-Torres, M. C. ;
Basu, S. ;
Chisholm, R. L. ;
Dodson, R. J. ;
Fey, P. ;
Thomas, P. D. ;
Mi, H. ;
Muruganujan, A. ;
Huang, X. ;
Poudel, S. ;
Hu, J. C. ;
Aleksander, S. A. ;
McIntosh, B. K. ;
Renfro, D. P. ;
Siegele, D. A. ;
Antonazzo, G. ;
Attrill, H. ;
Brown, N. H. ;
Marygold, S. J. ;
McQuilton, P. ;
Ponting, L. ;
Millburn, G. H. ;
Rey, A. J. ;
Stefancsik, R. ;
Tweedie, S. ;
Falls, K. ;
Schroeder, A. J. ;
Courtot, M. ;
Osumi-Sutherland, D. ;
Parkinson, H. ;
Roncaglia, P. ;
Lovering, R. C. ;
Foulger, R. E. ;
Huntley, R. P. ;
Denny, P. ;
Campbell, N. H. ;
Kramarz, B. ;
Patel, S. ;
Buxton, J. L. ;
Umrao, Z. ;
Deng, A. T. ;
Alrohaif, H. ;
Mitchell, K. ;
Ratnaraj, F. ;
Omer, W. ;
Rodriguez-Lopez, M. .
NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) :D331-D338
[10]   Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment [J].
Casaburi, Ivan ;
Chimento, Adele ;
De Luca, Arianna ;
Nocito, Marta ;
Sculco, Sara ;
Avena, Paola ;
Trotta, Francesca ;
Rago, Vittoria ;
Sirianni, Rosa ;
Pezzi, Vincenzo .
FRONTIERS IN ENDOCRINOLOGY, 2018, 9